Valuation : BELE LIFEPAR

Market Cap 46.6M 40.06M 37.69M 34.4M 64.19M 4.42B 64.52M 447M 173M 2.26B 175M 171M 7.18B P/E 2022 *
-
P/E 2023 210x
Enterprise Value 46.65M 40.11M 37.74M 34.44M 64.27M 4.42B 64.6M 447M 173M 2.26B 175M 171M 7.19B EV / Sales 2022 *
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -
1 day-10.22%
Current month-93.29%
Current year-93.29%
3 years 0.2
Extreme 0.196
13.4
5 years 0.2
Extreme 0.196
13.4
10 years 0.2
Extreme 0.196
13.4

Financials

2022 2023
Net sales - -
Net income -35.39K -30.43K -28.62K -26.12K -48.75K -3.35M -49K -339K -131K -1.71M -133K -130K -5.46M 404K 347K 327K 298K 556K 38.28M 559K 3.87M 1.5M 19.57M 1.52M 1.48M 62.26M
Net Debt 1.09M 939K 884K 806K 1.51M 104M 1.51M 10.47M 4.05M 52.94M 4.1M 4.01M 168M 56.58K 48.65K 45.77K 41.77K 77.94K 5.36M 78.35K 542K 210K 2.74M 212K 208K 8.72M
Logo BELE LIFEPAR
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.
Employees
-
Sector
-
Date Price Change
08/09/26 US$0.2020 -10.22%
04/09/26 US$0.2250 -8.14%
03/09/26 US$0.2450 -24.63%
02/09/26 US$0.3250 -3.70%
01/09/26 US$0.3375 +22.73%
  1. Stock Market
  2. Stocks
  3. BLAC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!